Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Financial Information Relating to Reportable Segments (Details)

v3.23.3
Segment Information - Financial Information Relating to Reportable Segments (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net $ 276,935 $ 269,655  
Operating income 55,862 56,317  
Costs recognized on sale of acquired inventory (181) (300)  
Impact of partially-owned consolidated subsidiaries   (179)  
Corporate general, selling, and administrative expenses (105,331) (99,375)  
Total intangible assets, net 578,971   $ 534,645
Operating Segments      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Operating income 88,888 94,580  
Costs recognized on sale of acquired inventory (181) (300)  
Amortization of intangibles (19,851) (19,283)  
Impact of partially-owned consolidated subsidiaries   647  
Acquisition related expenses and other 588 (297)  
Stock based compensation, inclusive of employer taxes (11,494) (15,458)  
Restructuring costs (89) (2,170)  
Operating Segments | Protein Sciences      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net 204,655 199,949  
Operating income 88,361 85,942  
Operating Segments | Diagnostics and Genomics      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net 72,797 69,904  
Operating income 527 8,638  
Intersegment Eliminations      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net (517) (198)  
Corporate, Non-Segment      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Corporate general, selling, and administrative expenses $ (1,999) $ (1,402)